JPS635036A - Squalene-containing composition - Google Patents
Squalene-containing compositionInfo
- Publication number
- JPS635036A JPS635036A JP14898286A JP14898286A JPS635036A JP S635036 A JPS635036 A JP S635036A JP 14898286 A JP14898286 A JP 14898286A JP 14898286 A JP14898286 A JP 14898286A JP S635036 A JPS635036 A JP S635036A
- Authority
- JP
- Japan
- Prior art keywords
- squalene
- containing composition
- antioxidant
- phospholipid
- phospholipids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 title claims abstract description 35
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 title claims abstract description 35
- 229940031439 squalene Drugs 0.000 title claims abstract description 35
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 title claims abstract description 35
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 title claims abstract description 34
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 18
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 9
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 7
- 239000003381 stabilizer Substances 0.000 claims abstract description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052760 oxygen Inorganic materials 0.000 abstract description 4
- 239000001301 oxygen Substances 0.000 abstract description 4
- 229930003799 tocopherol Natural products 0.000 abstract description 4
- 239000011732 tocopherol Substances 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract description 3
- 239000008158 vegetable oil Substances 0.000 abstract description 3
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 abstract description 2
- 208000007107 Stomach Ulcer Diseases 0.000 abstract description 2
- 230000004913 activation Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 208000019423 liver disease Diseases 0.000 abstract description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract description 2
- 150000008104 phosphatidylethanolamines Chemical class 0.000 abstract description 2
- 230000000087 stabilizing effect Effects 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 201000005917 gastric ulcer Diseases 0.000 abstract 1
- 238000005470 impregnation Methods 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 229960001295 tocopherol Drugs 0.000 abstract 1
- 235000010384 tocopherol Nutrition 0.000 abstract 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 abstract 1
- 150000002978 peroxides Chemical class 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 4
- 235000019345 sodium thiosulphate Nutrition 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 235000019149 tocopherols Nutrition 0.000 description 3
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000251730 Chondrichthyes Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical group CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical class OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- -1 etc.) Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 125000005313 fatty acid group Chemical group 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 125000005456 glyceride group Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical class [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000010686 shark liver oil Substances 0.000 description 1
- 229940069764 shark liver oil Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- YYGNTYWPHWGJRM-AAJYLUCBSA-N squalene group Chemical group CC(C)=CCC\C(\C)=C\CC\C(\C)=C\CC\C=C(/C)\CC\C=C(/C)\CCC=C(C)C YYGNTYWPHWGJRM-AAJYLUCBSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
Abstract
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は安定なスクアレン含有組成物に関する。[Detailed description of the invention] [Industrial application field] The present invention relates to stable squalene-containing compositions.
〔従来技術・発明が解決しようとする問題点〕スクアレ
ンは6個のイソプレン残基からなる炭素数30の鎖状構
造をもつ化合物であり、サメ類の肝油などに含まれる無
色の油状物で、深海鮫から取れるところからGiWj鮫
エキスとも呼ばれる。[Prior art/problems to be solved by the invention] Squalene is a compound with a chain structure of 30 carbon atoms consisting of 6 isoprene residues, and is a colorless oily substance found in shark liver oil. It is also called GiWj shark extract because it is extracted from deep-sea sharks.
近年スクアレンは、1916年に発見され、主として化
粧品原料として使用されてきたが、1974年になり、
栄養補助食品としての地位を占めるようになった。In recent years, squalene was discovered in 1916 and has been mainly used as a cosmetic raw material, but in 1974,
It has come to be considered a dietary supplement.
スクアレンの生理作用としては、たとえば次のごときも
のが例示される。Examples of the physiological effects of squalene include the following.
(1) 浸透性、賦活作用に冨み、胃潰瘍などの疾患
に効果を有し、
(2)肝臓疾患に有効(これは病んだ細胞に酸素を送り
、賦活性を与えるものではないかと考えられる)、
(3)細胞に酸素を運ぶ働きを有し、細胞に活力を与え
る
ところがスクアレンは高度な不飽和化合物であることか
ら安定性が悪く、酸素や熱等によって容易に劣化してし
まうことが問題点とされている。(1) Rich in permeability and activating effect, effective against diseases such as gastric ulcers; (2) Effective against liver diseases (this is thought to be a substance that sends oxygen to diseased cells and gives them activation) (3) Squalene has the function of transporting oxygen to cells and gives them vitality, but as it is a highly unsaturated compound, it has poor stability and is easily degraded by oxygen, heat, etc. is considered to be a problem.
従って、本発明の目的は、スクアレンの安定な組成物を
提供することである。It is therefore an object of the present invention to provide stable compositions of squalene.
本発明者はスクアレンの安定化について種々研究を重ね
てきたところ、リン脂質がスクアレンに対する安定化作
用を有することを見出し、本発明を完成した。The present inventor has conducted various studies on the stabilization of squalene, and has discovered that phospholipids have a stabilizing effect on squalene, and has completed the present invention.
即ち、本発明は、スクアレンの安定化剤として、リン脂
質から選ばれる少なくとも一種を配合してなることを特
徴とするスクアレン含有組成物に関するものであり、ま
た、本発明は当該組成物にさらに抗酸化剤を配合してな
るスクアレン含有組成物に関する。That is, the present invention relates to a squalene-containing composition characterized in that it contains at least one type selected from phospholipids as a squalene stabilizer, and the present invention also relates to a squalene-containing composition that is characterized by containing at least one type selected from phospholipids as a squalene stabilizer. The present invention relates to a squalene-containing composition containing an oxidizing agent.
スクアレンは6個のイソプレン残基からなる下記構造式 で表される鎖状構造を持つ。Squalene has the following structural formula consisting of 6 isoprene residues. It has a chain structure represented by .
スクアレンは高純度のものを使用するのが望ましく、組
成物中には20重量%以上、好ましくは30重量%以上
含有される。It is desirable to use squalene of high purity, and it is contained in the composition in an amount of 20% by weight or more, preferably 30% by weight or more.
本発明で安定化剤として使用されるリン脂質は、リンを
有する脂質の総称であり、グリセライドを基本骨格とし
たものや、そうでないものがあり、脂肪酸残基を1〜2
個有している。たとえばホスファチジルコリン、ホスフ
ァチジルエタノールアミン、スフィンゴミエリン等が例
示される。本発明で使用されるリン脂質は、上記リン脂
質単独は勿論のこと、上記リン脂質の混合物、上記リン
脂質含有物の態様で使用してもよい。特にレシチン(例
えば、大豆レシチン、卵黄レシチン)、水素添加レシチ
ン等の態様で使用することが好ましい。The phospholipid used as a stabilizer in the present invention is a general term for lipids containing phosphorus, and there are those that have a basic skeleton of glyceride and those that do not, and that have one to two fatty acid residues.
I have one. Examples include phosphatidylcholine, phosphatidylethanolamine, and sphingomyelin. The phospholipid used in the present invention may be used not only as the above-mentioned phospholipid alone, but also in the form of a mixture of the above-mentioned phospholipids, or a product containing the above-mentioned phospholipids. In particular, it is preferable to use lecithin (eg, soybean lecithin, egg yolk lecithin), hydrogenated lecithin, and the like.
本発明の組成物においてはスクアレン100重量部に対
し、リン脂質(例えばレシチン)は1重量部程度以上、
特に3重量部程度以上加えることが好ましい。In the composition of the present invention, the phospholipid (for example, lecithin) is about 1 part by weight or more per 100 parts by weight of squalene.
In particular, it is preferable to add about 3 parts by weight or more.
本発明は、さらに抗酸化剤を配合してなる組成物を提供
するものである。抗酸化剤としては、天然抗酸化剤が好
ましく、たとえばトコフェロール類等の植物油、フラボ
ン誘導体、没食子酸誘導体、カテキン酸、ステロール類
、テルペン類またはこれらを含有する植物抽出物等が挙
げられる。トコフェロール類含有植物としては、たとえ
ば小麦胚芽、綿の実、大豆等、フラボン誘導体含有植物
としては、たとえばサクラソウ属に属するもの、ジキタ
リス、甘草等、没食子酸誘導体含有物としては、たとえ
ば五倍子、没食子等、カテキン酸含有植物としては、た
とえばユーカリ属、ウルシ属の樹木等、ステロール類含
有植物としては、たとえばアブラナ、酵母、大豆等が例
示される。The present invention provides a composition further containing an antioxidant. The antioxidant is preferably a natural antioxidant, such as vegetable oils such as tocopherols, flavone derivatives, gallic acid derivatives, catechic acid, sterols, terpenes, or plant extracts containing these. Examples of plants containing tocopherols include wheat germ, cottonseed, soybeans, etc.; examples of plants containing flavone derivatives include those belonging to the genus Primrose, digitalis, licorice, etc.; examples of plants containing gallic acid derivatives include pentagrams, galls, etc. Examples of catechic acid-containing plants include trees of the genus Eucalyptus and Ursica, and examples of sterol-containing plants include rapeseed, yeast, and soybean.
抗酸化剤はスクアレン100重量部に対して1〜10重
量部配合されることが望ましい。It is desirable that the antioxidant be blended in an amount of 1 to 10 parts by weight per 100 parts by weight of squalene.
本発明の組成物においては、リン脂質、抗酸化剤に加え
て、更にリン脂質を溶解する物質、特にリン脂質および
スクアレンを溶解する物質を配合してもよい。熔解補助
剤としては、上記の抗酸化剤であるトコフェロール等の
植物油、テルペン類を含有する柑橘類抽出物を溶解補助
剤と兼ねて使用してもよく、他には植物油(米油、綿実
油、コーン油等)、有機溶媒、蛋白質分解物(コラーゲ
ン加水分解物等、好ましくは分子量1000〜3000
程度のもの等)を配合してもよい、当該物質の配合量は
、スクアレン及びリン脂質を溶解するに足る1以上であ
ればよい。In addition to phospholipids and antioxidants, the composition of the present invention may further contain a substance that dissolves phospholipids, particularly a substance that dissolves phospholipids and squalene. As the solubilizing agent, vegetable oils such as tocopherols, which are antioxidants mentioned above, and citrus extracts containing terpenes may also be used as solubilizing agents. oil, etc.), organic solvent, protein decomposition product (collagen hydrolyzate, etc., preferably with a molecular weight of 1000 to 3000)
The amount of the substance may be one or more sufficient to dissolve squalene and phospholipid.
本発明組成物にはさらにリン酸、クエン酸、アスコルビ
ン酸、メラノイジン、核酸、フェラル酸エステル等を配
合することにより、スクアレンの安定化が促進される。Stabilization of squalene is promoted by further blending phosphoric acid, citric acid, ascorbic acid, melanoidin, nucleic acid, feral acid ester, etc. into the composition of the present invention.
本発明の組成物は食品、栄養補助剤、医薬品等として使
用されるものである。かかる製品は、たとえば蜜ろう、
乳糖等を配合し、常套手段によって調製することが出来
る。The composition of the present invention is used as a food, a nutritional supplement, a pharmaceutical, and the like. Such products include, for example, beeswax,
It can be prepared by conventional means by blending lactose and the like.
実施例1〜5
以下の表1で示される組成を均質になるまで混合し、ス
クアレン含有組成物を製造した。なお表中の数字は重量
部を示す。Examples 1 to 5 The compositions shown in Table 1 below were mixed until homogeneous to produce squalene-containing compositions. Note that the numbers in the table indicate parts by weight.
(以下余白) 表 1 比較例1 スクアレン単品の製剤を作製した。(Margin below) Table 1 Comparative example 1 A single squalene formulation was prepared.
比較例2
スクアレン100重量部およびビタミンE2重量部から
なる組成物を作製した。Comparative Example 2 A composition consisting of 100 parts by weight of squalene and 2 parts by weight of vitamin E was prepared.
実験例1
実施例1〜5および比較例1.2の製剤を使用し、60
℃の恒温水浴中に蓋をせずに放置後、−定時間毎にその
一部を採取し、そこに含まれる過酸化物を定量し、過酸
化物価を求め、その結果を表2に示した。なお、表中の
括弧内の数字は0時間の数値をOとし、各測定時の過酸
化物価の変動を示す。Experimental Example 1 Using the formulations of Examples 1 to 5 and Comparative Example 1.2, 60
After leaving it uncovered in a constant temperature water bath at ℃, a portion of it was sampled at regular intervals, the peroxide contained therein was quantified, and the peroxide value was determined. The results are shown in Table 2. Ta. Note that the numbers in parentheses in the table indicate the change in peroxide value at each measurement time, with the value at 0 hours being O.
過酸化物の定量方法および過酸化物価の求め方:試料1
0gを共セン付三角フラスコに正しく採取し、溶剤(ク
ロロホルム2:氷酢酸3)60−を加え、静かに振りま
ぜて透明に溶かす。Method for quantifying peroxide and determining peroxide value: Sample 1
0 g was properly collected in an Erlenmeyer flask with a co-sensor, 60 - of a solvent (chloroform: 2: glacial acetic acid: 3) was added, and the mixture was gently shaken to dissolve it into a transparent solution.
飽和ヨウ化カリウム溶液in/を加え、直ちに共センを
して1分間振りまぜ、水60I117を加え、デンプン
溶液を指示薬として、0.0INチオ硫酸ナトリウム溶
液で滴定する。デンプンによる着色が消失するときを終
点とする。空試験を並行して行う。Add saturated potassium iodide solution in/and immediately mix for 1 minute, add 60I117 of water, and titrate with 0.0IN sodium thiosulfate solution using starch solution as an indicator. The end point is when the coloring caused by starch disappears. A blank test will be conducted in parallel.
過酸化物価は次の式で求められる。The peroxide value is determined by the following formula.
過酸化物価(■当量/kg)=(A−B)XFX10+
CA−本試験のチオ硫酸ナトリウム溶液使用量(a/)
B=空試験のチオ硫酸ナトリウム溶液使用量(−)C=
試料採取量(g)
F=チオ硫酸ナトリウム溶液の力価
(余白)
」
〔効果〕
リン脂質はスクアレンに対して優れた安定他作Mを有す
る。従って、スクアレンにリン脂質を配きした組成物は
、そこに含まれるスクアレンが安?に存在する。Peroxide value (■equivalent/kg) = (A-B)XFX10+
CA-Amount of sodium thiosulfate solution used in this test (a/)
B = Amount of sodium thiosulfate solution used in blank test (-) C =
Amount of sample collected (g) F = Potency of sodium thiosulfate solution (margin) [Effect] Phospholipid has excellent stability against squalene. Therefore, in compositions in which phospholipids are added to squalene, is the squalene contained therein cheap? exists in
し二白Shinihaku
Claims (2)
れる少なくとも一種を配合してなることを特徴とするス
クアレン含有組成物。(1) A squalene-containing composition comprising at least one selected from phospholipids as a squalene stabilizer.
(1)項記載の組成物。(2) The composition according to claim (1), further comprising an antioxidant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14898286A JPS635036A (en) | 1986-06-25 | 1986-06-25 | Squalene-containing composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14898286A JPS635036A (en) | 1986-06-25 | 1986-06-25 | Squalene-containing composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS635036A true JPS635036A (en) | 1988-01-11 |
Family
ID=15465045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14898286A Pending JPS635036A (en) | 1986-06-25 | 1986-06-25 | Squalene-containing composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS635036A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2834639A1 (en) * | 2002-01-11 | 2003-07-18 | Medix Lab | Topically applied dermatological or cosmetic composition, used e.g. for promoting skin regeneration and treating edema, contains flavonoid and vegetable oil containing linoleic and/or alpha-linolenic acid |
ES2275435A1 (en) * | 2005-11-18 | 2007-06-01 | Farmaleis, S.L. | A combination comprising squalene, a phospholipid and an omega 3 fatty acid for the treatment of cancer |
JP2011144134A (en) * | 2010-01-15 | 2011-07-28 | Tosoh Finechem Corp | Diethylzinc composition, heat stabilization method, and compound for use in heat stabilization |
KR20200091896A (en) | 2017-12-06 | 2020-07-31 | 가부시키가이샤 사카타노타네 | Production method of lactoca plant seeds using scissors bee |
-
1986
- 1986-06-25 JP JP14898286A patent/JPS635036A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2834639A1 (en) * | 2002-01-11 | 2003-07-18 | Medix Lab | Topically applied dermatological or cosmetic composition, used e.g. for promoting skin regeneration and treating edema, contains flavonoid and vegetable oil containing linoleic and/or alpha-linolenic acid |
ES2275435A1 (en) * | 2005-11-18 | 2007-06-01 | Farmaleis, S.L. | A combination comprising squalene, a phospholipid and an omega 3 fatty acid for the treatment of cancer |
JP2011144134A (en) * | 2010-01-15 | 2011-07-28 | Tosoh Finechem Corp | Diethylzinc composition, heat stabilization method, and compound for use in heat stabilization |
KR20200091896A (en) | 2017-12-06 | 2020-07-31 | 가부시키가이샤 사카타노타네 | Production method of lactoca plant seeds using scissors bee |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3005226B2 (en) | Method for producing antioxidant mixture | |
JP3103430B2 (en) | Fat-soluble antioxidant mixture | |
EP0180786B2 (en) | Pharmaceutical or dietetic composition having a high antithrombotic and antiarteriosclerotic activity | |
US9301536B2 (en) | Antioxidant composition for marine oils comprising tocopherol, rosemary extract, ascorbic acid and green tea extract | |
US5258179A (en) | Protection of a food, cosmetic or pharmaceutical product against oxidation | |
DE60317639T2 (en) | COMPOSITIONS CONTAIN N-ACYL-PHOSPHATIDYL-ETHANOLAMINE AND / OR MIXTURES OF N-ACYL-ETHANOLAMINES WITH PHOSPHATIDINIC ACIDS OR LYSOPHOSPHATIDINIC ACIDS | |
EP0084341B1 (en) | Emulsion-type composition for external use | |
JP3081226B2 (en) | Method for preventing oxidation of fats or fat-containing products | |
EP0577305B1 (en) | Antioxidant compositions | |
JPS635036A (en) | Squalene-containing composition | |
JPS60192547A (en) | Edible liquid compounded oil | |
JP3715345B2 (en) | Method of adding water-soluble active ingredients to fat | |
JP2001122884A (en) | Method for producing oil-soluble composition having high content of phosphatidyl serine | |
EP0303970B1 (en) | Surfactant composition having improved functions | |
JP3550176B2 (en) | Tocopherol-enriched refined sesame oil, fat infusion containing it and oral preparation | |
JPS60192546A (en) | Edible liquid compounded oil | |
JPS62187425A (en) | Composition containing linolenic acid and its derivative | |
JPS5944357B2 (en) | Antioxidant | |
WO1987007263A1 (en) | Composition containing linolenic acid compound | |
JP2020150822A (en) | Oils and fats, method for producing oils and fats, and oxidation inhibitor for oils and fats | |
Gunstone | Scottish Crop Research Institute, Invergowrie, Dundee, Scotland | |
JPH01307437A (en) | Safe lipid composition having high surface activity |